Mesa Laboratories, Inc.

Mesa Laboratories develops, manufactures, sells, and services life sciences tools and quality control products. The Sterilization and Disinfection Control segment offers indicators for assessing sterilization decontamination, disinfection, and cleaning processes. This segment also provides testing and laboratory services to dental and pharmaceutical industries. The Clinical Genomics segment offers genetic analysis tool systems, including MassARRAY and consumables. The Biopharmaceutical Development segment provides automated systems, instruments, and kits for protein analysis and peptide synthesis. The Calibration Solutions segment offers quality control products for measuring critical parameters in various applications.

Overview

Sector

Scientific Instruments

Target Price

0.0 USD

Current Price

68.4 USD

Potential

-100%

Strengths

Price to book ratio (2.32) is lower than the sector mean (11.67).
The company has high returns. ROIC (13.71%) is higher than the sector mean (7.53%).
Price to free cash flow (8.75) is lower than the sector mean.

Weaknesses

With a depreciation Potential of -100.00%, based on our fundamental analysis, it suggests the stock may be overvalued.
Analysts expect revenues to decline in the coming year.
The company has high debt. Net Debt to EBITDA Ratio (3.91) is higher than the sector mean.

Key Financial Data

Indicator	Value
PER	100.0
EV/EBITDA	13.4
Price/Free Cash Flow'	8.8
ROIC	13.7%
Net Debt/EBITDA	3.9